Corvus Pharmaceuticals EPS Basic from Other Gains / Loss (Quarterly) Analysis

Corvus Pharmaceuticals, Inc. (CRVS)

17.82 +0.61 (+3.54%) USD | NASDAQ | Feb 24, 16:00

17.73 -0.09 (-0.51%) After-Hours: 06:59

View EPS Basic from Other Gains / Loss (Quarterly) for CRVS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Basic from Other Gains / Loss (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Basic from Other Gains / Loss (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Basic from Other Gains / Loss (Quarterly) Benchmarks

Start Trial

Regeneron Pharmaceuticals, Inc.	--
Plus Therapeutics, Inc.	--
Geron Corp.	--
Jaguar Health, Inc.	--
Krystal Biotech, Inc.	--